Cardiorespiratory fitness on a treadmill in an adult cystic fibrosis population

被引:0
|
作者
Torvanger, Ole [1 ,2 ,3 ]
Os, Audun [2 ,3 ]
Skjonsberg, Ole Henning [1 ,2 ]
Edvardsen, Elisabeth [2 ,4 ]
机构
[1] Univ Oslo, Fac Med, Oslo, Norway
[2] Oslo Univ Hosp, Dept Pulm Med, Oslo, Norway
[3] Oslo Univ Hosp, Norwegian Resource Ctr Cyst Fibrosis, Oslo, Norway
[4] Norwegian Sch Sport & Sci, Sports Med, Oslo, Norway
来源
BMJ OPEN SPORT & EXERCISE MEDICINE | 2020年 / 6卷 / 01期
关键词
exercise testing; pulmonary; respiratory; physiology; EXERCISE CAPACITY; PHYSICAL-ACTIVITY; REFERENCE VALUES; OXYGEN-UPTAKE; TOLERANCE;
D O I
10.1136/bmjsem-2020-000765
中图分类号
G8 [体育];
学科分类号
04 ; 0403 ;
摘要
Objectives(1) To describe the cardiorespiratory fitness (CRF) in an adult cystic fibrosis population related to sex and age, (2) to evaluate the cause of low CRF and (3) to study the association between peak oxygen uptake (VO(2)peak) and forced expiratory volume in 1 s (FEV1).MethodsA total of 204 cardiopulmonary treadmill exercise tests (CPETs) performed by 116 patients were included. VO(2)peak, gas exchange, heart rate, oxygen saturation and ventilatory variables were measured.A low CRF was defined as a VO(2)peak <80% of predicted, ventilatory limitation was defined as a breathing reserve <15%, exercise hypoxaemia was defined as an oxygen saturation <88% and ventilation-perfusion mismatch was defined as a minute ventilation/ventilatory equivalent for carbon dioxide slope <greater than or equal to>34. In patients who had performed three or more CPETs, the annual change in FEV1 and VO(2)peak were calculated using linear regression.ResultsThe VO(2)peak was 40.611.5and 35.2 +/- 8.9mL kg(-1) min(-1), which was 87 +/- 23and 93 +/- 20 in percentage of predicted for men and women, respectively. VO(2)peak was moderately affected by age, for men (r=-0.36, p<0.001) and women (r=-0.53, p<0.001), respectively. In 45 of 101 tests where CRF was low, no cardiorespiratory limiting factors were identified. The correlation coefficient between VO(2)peak and FEV1 was r=0.64 (p<0.001). In participants with a low CRF, FEV1 ranged from 20% to 112% of predicted.ConclusionsThe correlation between VO(2)peak and FEV1 was moderate. The majority of the tests resulted in a VO(2)peak within normal limits. Interestingly, 44% of the tests with a low VO(2)peak could be explained by deconditioning. Thus, exercise therapy may be beneficial for these patients.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Cardiorespiratory Fitness in an adult Norwegian Cystic Fibrosis Population
    Torvanger, Ole
    Os, Audun
    Skjonsberg, Ole Henning
    Edvardsen, Elisabeth
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [2] EDEMA INDEX AS A PREDICTOR FOR CARDIORESPIRATORY FITNESS IN THE ADULT US POPULATION
    Marawan, Amr
    Kurbanova, Nargiza
    Qayyum, Rehan
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 1893 - 1893
  • [3] Cystic fibrosis - characterization of the adult population in Portugal
    Silva, A.
    Amorim, A.
    Azevedo, P.
    Lopes, C.
    Gamboa, F.
    [J]. REVISTA PORTUGUESA DE PNEUMOLOGIA, 2016, 22 (03) : 141 - 145
  • [4] Nutritional status of an adult cystic fibrosis population
    Richardson, I
    Nyulasi, I
    Cameron, K
    Ball, M
    Wilson, J
    [J]. NUTRITION, 2000, 16 (04) : 255 - 259
  • [5] Physiological predictors of cardiorespiratory fitness in children and adolescents with cystic fibrosis without ventilatory limitation
    Burghard, Marcella
    Takken, Tim
    Nap-van der Vlist, Merel M.
    Nijhof, Sanne L.
    van der Ent, C. Kors
    Heijerman, Harry G. M.
    Hulzebos, H. J. Erik
    [J]. THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2022, 16
  • [6] Physiological predictors of cardiorespiratory fitness in children and adolescents with cystic fibrosis without ventilatory limitation
    Burghard, Marcella
    Takken, Tim
    van der Vlist, Merel M.
    Nijhof, Sanne L.
    van der Ent, C. Kors
    Heijerman, Harry G. M.
    Hulzebos, H. J. Erik
    [J]. THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2022, 16
  • [7] MUSCULOSKELETAL AND SEROLOGICAL FINDINGS IN AN ADULT CYSTIC FIBROSIS POPULATION
    Mewa, S.
    Elarabi, M.
    Griffin, K.
    Mahendira, L.
    Sykes, J.
    Norris, E.
    Stephenson, A.
    Tullis, E.
    Rubin, L.
    [J]. PEDIATRIC PULMONOLOGY, 2016, 51 : 376 - 377
  • [8] Population Pharmacokinetics of Amikacin in Adult Patients with Cystic Fibrosis
    Illamola, Silvia M.
    Huynh, Hoa Q.
    Liu, Xiaoxi
    Bhakta, Zubin N.
    Sherwin, Catherine M.
    Liou, Theodore G.
    Carveth, Holly
    Young, David C.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (10)
  • [9] Optimising inhaled mannitol for cystic fibrosis in an adult population
    Flume, Patrick A.
    Aitken, Moira L.
    Bilton, Diana
    Agent, Penny
    Charlton, Brett
    Forster, Emma
    Fox, Howard G.
    Hebestreit, Helge
    Kolbe, John
    Zuckerman, Jonathan B.
    Button, Brenda M.
    [J]. BREATHE, 2015, 11 (01) : 39 - 48
  • [10] Presence of diabetic complications in an adult cystic fibrosis population
    Elston, C.
    Fairhurst, M.
    Scott, S.
    Bridges, N.
    Shotliff, K.
    Gyi, K.
    [J]. PEDIATRIC PULMONOLOGY, 2007, : 396 - 396